Article
Serum Levels of PSPH and CXCL2 as Predictors of Treatment Response in Male Patients with First-Episode Schizophrenia: A Single-Center Retrospective Study
2025-07-18
Abstract excerpt
<title>Abstract</title> <p> <bold>Objective</bold> To evaluate serum levels of Phosphoserine Phosphatase (PSPH) and Chemokine C-X-C Motif Ligand 2 (CXCL2) as biomarkers for predicting antipsychotic treatment response in male first-episode schizophrenia patients. <bold>Methods</bold> Bioinformatics analysis identified upregulated PSPH and CXCL2 expression in PBMCs of schizophrenia patients. Clinical data from...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5181238c-61ab-5a1f-85ab-850827402f9b
- DOI
- 10.21203/rs.3.rs-6877454/v1
